ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
54,50 € 0,00 (0,00%)
2023-08-21
AKTIENPREIS
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionComerica Bank
Latest Disclosed Ownership8,754 shares
Latest Disclosed Value $ 690,996
Comerica Bank reports 6.67% decrease in ownership of BSFA / ANI Pharmaceuticals, Inc.

On January 29, 2026 - Comerica Bank filed a 13F-HR form disclosing ownership of 8,754 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $690,996 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 9,380 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of -6.67% during the quarter. The current value of the position is $477,093 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 8,754 -626 -6.67 691 -19.67 0.0028
2025-11-14 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,380 -2,086 -18.19 859 14.84 0.0032
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 11,466 -84 -0.73 748 -3.23 0.0029
2025-05-14 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,550 -7,280 -38.66 773 -25.67 0.0032
2025-02-14 2024-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 18,830 -8,099 -30.08 1,041 -35.24 0.0042
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 18,830 -8,099 1,041 0.0035
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 26,929 3,366 14.29 1,607 7.07 0.0064
2024-08-15 2024-06-30 13F ANI PHARMACEUTICALS COMMON 00182C103 23,563 -13,100 -35.73 1,500 -40.81 0.0062
2024-05-16 2024-03-31 13F ANI PHARMACEUTICALS COMMON 00182C103 36,663 -192 -0.52 2,534 24.70 0.0109
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COMMON 00182C103 36,855 1,626 4.62 2,032 -0.64 0.0094
2023-11-21 2023-09-30 13F ANI PHARMACEUTICALS COMMON 00182C103 35,229 35,229 2,045 0.0107
2023-08-22 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -47,309 -100.00 0 -100.00
2023-01-26 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 47,309 -643 -1.34 2 -99.94 0.0154
2022-10-28 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 47,952 36,767 328.72 1,770 400.00 0.0149
2022-08-02 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 11,185 -10 -0.09 354 -3.54 0.0029
2022-04-27 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,195 2,655 31.09 367 3.97 0.0027
2022-02-18 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 8,540 178 2.13 353 14.61 0.0026
2021-11-22 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 8,362 -394 -4.50 308 32.76 0.0019
2021-08-26 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 8,756 -547 -5.88 232 -24.43 0.0014
2021-04-28 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 9,303 -390 -4.02 307 -1.29 0.0018
2021-01-28 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 9,693 66 0.69 311 11.47 0.0020
2020-10-30 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,627 -58 -0.60 279 0.00 0.0020
2020-07-31 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,685 698 7.77 279 -25.60 0.0021
2020-05-01 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 8,987 246 2.81 375 -29.91 0.0034
2020-02-07 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 8,741 23 0.26 535 -20.97 0.0041
2019-10-31 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 8,718 790 9.96 677 5.62 0.0054
2019-08-02 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 7,928 -311 -3.77 641 12.46 0.0051
2019-05-02 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 8,239 248 3.10 570 35.39 0.0046
2019-02-06 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 7,991 -74 -0.92 421 -6.24 0.0036
2018-11-01 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 8,065 -1,547 -16.09 449 -33.28 0.0036
2018-08-01 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,612 292 3.13 673 19.12 0.0047
2018-05-01 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 9,320 153 1.67 565 -11.16 0.0040
2018-02-02 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 9,167 -240 -2.55 636 15.43 0.0042
2017-11-06 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,407 1,102 13.27 551 36.05 0.0040
2017-08-03 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 8,305 -550 -6.21 405 -16.67 0.0030
2017-05-03 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 8,855 323 3.79 486 -4.33 0.0037
2017-02-08 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 8,532 451 5.58 508 -8.14 0.0040
2016-11-10 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 8,081 430 5.62 553 3.36 0.0326
2016-08-11 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 7,651 -172 -2.20 535 58.28 0.0046
2016-05-11 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 7,823 32 0.41 338 11.18 0.0030
2016-02-05 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 7,791 149 1.95 304 0.66 0.0030
2015-11-12 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 7,642 -8,888 -53.77 302 -70.57 0.0029
2015-08-13 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 16,530 8,496 105.75 1,026 103.98 0.0044
2015-05-15 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 8,034 8,034 503 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.